BULLFROG AI HOLDINGS, INC. Operating Cash Flow
BULLFROG AI HOLDINGS, INC. (BFRG) reported Operating Cash Flow of -$3.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- BULLFROG AI HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.51M.
- BULLFROG AI HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.69M.
- BULLFROG AI HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.18M.
- BULLFROG AI HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.11M.
- BULLFROG AI HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$5.52M.
- BULLFROG AI HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$5.61M.
- BULLFROG AI HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$6.00M.
- BULLFROG AI HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$910.89K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$3.21M 10-Q · filed 2026-08-14 | -$4.39M derived: sum of 3 quarters · filed 2026-08-14 | -$5.50M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$1.69M 10-Q · filed 2026-05-14 | -$2.88M derived: sum of 2 quarters · filed 2026-05-14 | -$3.99M derived: sum of 3 quarters · filed 2026-05-14 | -$5.42M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$2.29M derived: sum of 2 quarters · filed 2026-03-19 | -$3.72M derived: sum of 3 quarters · filed 2026-08-14 | -$5.52M 10-K · filed 2026-03-19 |
| 2025-09-30 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.54M derived: sum of 2 quarters · filed 2026-08-14 | -$4.34M 10-Q · filed 2025-11-14 | -$5.61M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$3.23M 10-Q · filed 2026-08-14 | -$4.50M derived: sum of 3 quarters · filed 2026-08-14 | -$5.71M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$1.80M 10-Q · filed 2026-05-14 | -$3.07M derived: sum of 2 quarters · filed 2026-05-14 | -$4.28M derived: sum of 3 quarters · filed 2026-05-14 | -$5.51M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$2.48M derived: sum of 2 quarters · filed 2026-03-19 | -$3.71M derived: sum of 3 quarters · filed 2026-03-19 | -$5.61M 10-K · filed 2026-03-19 |
| 2024-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.44M derived: sum of 2 quarters · filed 2025-11-14 | -$4.34M 10-Q · filed 2025-11-14 | -$5.36M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$3.13M 10-Q · filed 2025-08-13 | -$4.15M derived: sum of 3 quarters · filed 2025-08-13 | -$5.54M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$1.90M 10-Q · filed 2025-05-13 | -$2.92M derived: sum of 2 quarters · filed 2025-05-13 | -$4.31M derived: sum of 3 quarters · filed 2025-05-13 | -$5.54M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$2.41M derived: sum of 2 quarters · filed 2025-03-14 | -$3.64M derived: sum of 3 quarters · filed 2025-03-14 | -$6.00M 10-K · filed 2025-03-14 |
| 2023-09-30 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$2.62M derived: sum of 2 quarters · filed 2024-11-08 | -$4.98M 10-Q · filed 2024-11-08 | -$5.02M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$3.59M 10-Q · filed 2024-08-07 | -$3.63M derived: sum of 3 quarters · filed 2024-08-07 | -$3.89M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$2.36M 10-Q · filed 2024-05-10 | -$2.40M derived: sum of 2 quarters · filed 2024-05-10 | -$2.66M derived: sum of 3 quarters · filed 2024-05-10 | -$3.26M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$39.65K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$298.88K derived: sum of 2 quarters · filed 2024-03-29 | -$901.12K derived: sum of 3 quarters · filed 2024-03-29 | -$910.89K 10-K · filed 2024-03-29 |
| 2022-09-30 | -$259.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$861.47K derived: sum of 2 quarters · filed 2023-11-14 | -$871.24K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$602.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$612.01K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$9.78K 10-Q · filed 2023-05-24 | |||
| 2021-12-31 | -$382.40K 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |